Le Roux CW - Search Results

1

Enhanced fasting and post-prandial plasma bile acid responses after Roux-en-Y gastric bypass surgery.

Werling M, Vincent RP, Cross GF, Marschall HU, Fändriks L, Lönroth H, Taylor DR, Alaghband-Zadeh J, Olbers T, Le Roux CW. Werling M, et al. Among authors: le roux cw. Scand J Gastroenterol. 2013 Nov;48(11):1257-64. doi: 10.3109/00365521.2013.833647. Epub 2013 Sep 18. Scand J Gastroenterol. 2013. PMID: 24044585

2

A new antiglycolytic agent.

le Roux CW, Wilkinson SD, Pavitt DV, Muller BR, Alaghband-Zadeh J. le Roux CW, et al. Ann Clin Biochem. 2004 Jan;41(Pt 1):43-6. doi: 10.1258/000456304322664681. Ann Clin Biochem. 2004. PMID: 14713384

3

Postprandial plasma ghrelin is suppressed proportional to meal calorie content in normal-weight but not obese subjects.

le Roux CW, Patterson M, Vincent RP, Hunt C, Ghatei MA, Bloom SR. le Roux CW, et al. J Clin Endocrinol Metab. 2005 Feb;90(2):1068-71. doi: 10.1210/jc.2004-1216. Epub 2004 Nov 2. J Clin Endocrinol Metab. 2005. PMID: 15522935

4

Attenuated peptide YY release in obese subjects is associated with reduced satiety.

le Roux CW, Batterham RL, Aylwin SJ, Patterson M, Borg CM, Wynne KJ, Kent A, Vincent RP, Gardiner J, Ghatei MA, Bloom SR. le Roux CW, et al. Endocrinology. 2006 Jan;147(1):3-8. doi: 10.1210/en.2005-0972. Epub 2005 Sep 15. Endocrinology. 2006. PMID: 16166213

5

New agents in development for the management of obesity.

Vincent RP, le Roux CW. Vincent RP, et al. Among authors: le roux cw. Int J Clin Pract. 2007 Dec;61(12):2103-12. doi: 10.1111/j.1742-1241.2007.01558.x. Epub 2007 Sep 10. Int J Clin Pract. 2007. PMID: 17850307 Free article. Review.

6

Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass.

le Roux CW, Welbourn R, Werling M, Osborne A, Kokkinos A, Laurenius A, Lönroth H, Fändriks L, Ghatei MA, Bloom SR, Olbers T. le Roux CW, et al. Ann Surg. 2007 Nov;246(5):780-5. doi: 10.1097/SLA.0b013e3180caa3e3. Ann Surg. 2007. PMID: 17968169 Clinical Trial.

7

Changes in gut hormones after bariatric surgery.

Vincent RP, le Roux CW. Vincent RP, et al. Among authors: le roux cw. Clin Endocrinol (Oxf). 2008 Aug;69(2):173-9. doi: 10.1111/j.1365-2265.2007.03164.x. Epub 2007 Dec 20. Clin Endocrinol (Oxf). 2008. PMID: 18167136 Review.

8

Supraphysiological doses of intravenous PYY3-36 cause nausea, but no additional reduction in food intake.

le Roux CW, Borg CM, Murphy KG, Vincent RP, Ghatei MA, Bloom SR. le Roux CW, et al. Ann Clin Biochem. 2008 Jan;45(Pt 1):93-5. doi: 10.1258/acb.2007.007068. Ann Clin Biochem. 2008. PMID: 18275682

9

Mechanisms of disease: the role of gastrointestinal hormones in appetite and obesity.

Vincent RP, Ashrafian H, le Roux CW. Vincent RP, et al. Among authors: le roux cw. Nat Clin Pract Gastroenterol Hepatol. 2008 May;5(5):268-77. doi: 10.1038/ncpgasthep1118. Epub 2008 Apr 1. Nat Clin Pract Gastroenterol Hepatol. 2008. PMID: 18382432 Review.

10

The satiety hormone peptide YY as a regulator of appetite.

Vincent RP, le Roux CW. Vincent RP, et al. Among authors: le roux cw. J Clin Pathol. 2008 May;61(5):548-52. doi: 10.1136/jcp.2007.048488. J Clin Pathol. 2008. PMID: 18441153 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

473 results

Search Page

Filters